AzTrials
AzTrials

Pecha KukaNCT07655765

The Effect of Breastfeeding Education Using the Pecha Kucha Technique on Breastfeeding Self-Efficacy and Breastfeeding Success in the Early Postpartum Period: A Randomized Controlled Trial

A study testing pecha kucha in people with Pecha Kuka, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Breast milk is considered the most biologically appropriate source of nutrition, essential for the healthy growth and development of newborns. Thanks to its optimal nutrients, immunological factors, and growth regulators, it not only meets nutritional needs but also protects against infections, reducing neonatal… Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Pecha Kuka
What is being tested?
pecha kucha
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteTurkey (Türkiye)
Study dates
13 Jun 2026to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • - Being primiparous
  • Having a full-term, singleton birth
  • Having a healthy newborn
  • Having a spontaneous vaginal birth

Who cannot join

  • Being multiparous (having given birth more than once)
  • Having given birth preterm or postterm
  • Having a mother or newborn with health problems
  • Having had a multiple pregnancy
  • Having had a cesarean section

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yasemin, AYDIN KARTAL, Prof. Dr. contact

(0216) 777 87 77

yasemin.aydin@sbu.edu.tr

Merve N KAYADUMAN, Midwife contact

(0216) 777 87 77

merve.kydmn@gmail.com

Turkey (Türkiye)1 site
  • Sağlık Bilimleri Üniversitesi, İstanbul,

    Istanbul

    Merve N KAYADUMAN, Midwife, (0216) 777 87 77, merve.kydmn@gmail.com

Other trials in Turkey (Türkiye)

About this study

Breast milk is considered the most biologically appropriate source of nutrition, essential for the healthy growth and development of newborns. Thanks to its optimal nutrients, immunological factors, and growth regulators, it not only meets nutritional needs but also protects against infections, reducing neonatal morbidity and mortality rates. The Pecha Kucha presentation technique keeps presentations concise and dynamic, creating a fast-paced, light, and engaging experience. It minimizes distractions and maximizes engagement. Because there is no text to read in the Pecha Kucha technique, presenters are required to be more prepared and strive to create a coherent narrative, resulting in a flawless narrative. Thus, the aim is to ensure the success and effectiveness of breastfeeding education with this technique, and ultimately, to promote breastfeeding education using the Pecha Kucha technique to healthcare professionals. The population of this randomized, controlled experimental study consists of primiparous postpartum women who gave birth in the Obstetrics Department of the Physical Therapy Annex Building of the Gaziosmanpaşa Training and Research Hospital at the University of Health Sciences. A power analysis was conducted using the G*Power package program, Version 3.1.9.4, to determine the sample size of the study. Because no similar research was found in the literature, Cohen's medium effect size was chosen as the effect size, anticipating that tests assessing the difference between two independent groups would be used when examining the differences in variables between the control and intervention groups. Accordingly, with 64 participants in the control group and 64 in the intervention group, a power of 80% was calculated at a significance level of 0.5 (medium) effect size and 0.05, and a minimum sample size of 128 was determined. The study, planned using an experimental design, is planned to be conducted on two groups: an intervention and a control group. Within the scope of the study, pretest data will be collected by administering the Breastfeeding Self-Efficacy Scale and the LATCH Breastfeeding Diagnostic and Assessment Scale, along with an introductory information form, to postpartum women who agree to participate in the study.

Conditions
Pecha Kuka
Being tested
pecha kucha
Keywords
pecha kucha, breast feeding, postpartum period
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pecha kuchaOther

    Training will be provided using training material consisting of 20 slides, each lasting 20 seconds, prepared using the 'Pecha Kucha' technique, for a total duration of 6 minutes and 20 seconds.

Study groups in NCT07655765
Study groupRoleWhat they receive
intervention groupExperimentalMothers in the intervention group will receive breastfeeding training using the Pecha Kucha presentation technique at the first hour postpartum
Receives: Other: pecha kucha
control groupNo interventionStandard breastfeeding education, as part of the routine postpartum care practices of the Ministry of Health, will be given to the puerperal women in the control group at the first hour postpartum.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. introductory information form

    This form, created by researchers based on literature, includes questions about the participants' age, high school graduation, their self-sufficiency against disasters, etc.

    Measured: 10 minitus

  2. Breastfeeding Self-Efficacy Scale

    The Breastfeeding Self-Efficacy Scale was developed by the National Institutes of Health (NIH) to assess mothers' breastfeeding self-efficacy levels. The initial form consisted of 33 items. In 2003, the scale was shortened to a 14-item version.Dennis recommends using the short form. The Breastfeeding Self-Efficacy Short Form Scale is a 5-point Likert-type scale (1 = Not at all confident and 5 = Always confident). The lowest possible score is 14, and the highest is 70. As the score increases, breastfeeding self-efficacy also increases. The validity and reliability of the scale in Turkey were conducted by Aluş Tokat, Okumus, and Dennis (2010). The scale is a 5-point Likert-type scale, with scores ranging from Not at all confident (1 point) to Always confident (5 points). The minimum possible score is 14, and the maximum score is 70. There is no cut-off point for the scale. A higher score indicates higher breastfeeding self-efficacy. The Cronbach's alpha for the scale was found to be0.87

    Measured: 10 minutes

  3. Latch Breastfeeding Diagnostic and Assessment Scale

    The LATCH Breastfeeding Diagnostic Measurement Tool was developed by Jensen and colleagues (1994). LATCH is a diagnostic tool created by simulating the Apgar scoring system in terms of its scoring method. It is a quick and easy scale to evaluate (Jensen, Wallace 1994). The Turkish validation of the tool was conducted by Demirhan in 1997, Koyun in 2001, and Yenal and Okumuş in 2003, and it was recommended as a reliable tool. The lowest score obtained from the scale is 0, and the highest is 10. A higher score indicates breastfeeding success. The Cronbach's alpha value of the LATCH Breastfeeding Diagnostic Measurement Tool was found to be 0.95 by Yenal and Okumuş.

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2026
  2. Study start13 Jun 2026 (estimated)
  3. Primary completion1 Jul 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Controlled Trial
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07655765
Sponsor's protocol ID
SBU-AYDINKARTAL-KAYADUMAN
Status last verified
Jun 2026
First submitted
13 Jun 2026
Last updated
18 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing pecha kucha in people with Pecha Kuka, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yasemin, AYDIN KARTAL, Prof. Dr. ((0216) 777 87 77, yasemin.aydin@sbu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

introductory information form (time frame: 10 minitus). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in